Anavex Life Sciences Corp (AVXL)

[imho]

Nothing here is screwed up if the FDA is the one recommending the changes.

Lying or not, I don't know. But if the FDA did in fact make these recommendations, it is a game changer. Given this from the PR,

“This is now the second successful placebo-controlled study of ANAVEX®2-73 in adult patients with Rett syndrome, and this Phase 3 study builds on the platform potential of ANAVEX®2-73 and its ability to demonstrate clinically meaningful improvements in Rett syndrome symptoms in the ANAVEX®2-73 treatment group compared to placebo,”

it may imply the FDA is coming around to the "platform potential" mentioned above.

IMHO